benefits of glp-1 drugs Can one drug do it all? Reviewing the expanding clinical universe agonists benefits of glp 1 agonists
Description
ABSTRACT Diabetic kidney disease (DKD) is a leading cause of end-stage kidney disease and significantly increases cardiovascular risk and mortality
Besides, our results suggest that GLP-1RAs may not affect Pulmonary hypertension
head-up position for induction of anaesthesia
However, the emergence of several drugs that mimic the effect of the GLP-1 hormone including Wegovy, Ozempic, and Mounjaro is probably the most promising avenue so far
1 dicembre 2022;257:113967
